Cargando…

Incident pulmonary arterial hypertension associated with Bosutinib

Pulmonary arterial hypertension is associated with tyrosine kinase inhibitors used in the treatment of chronic myeloid leukemia. Dasatinib is a known cause of drug-induced pulmonary arterial hypertension. There have been case reports linking Bosutinib with deterioration of pre-existing pulmonary art...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yo, Shaun, Thenganatt, John, Lipton, Jeffrey, Granton, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443988/ https://www.ncbi.nlm.nih.gov/pubmed/32913629 http://dx.doi.org/10.1177/2045894020936913

Ejemplares similares

A case of worsening pulmonary arterial hypertension and pleural effusions by bosutinib after prior treatment with dasatinib
por: Seegobin, Karan, et al.
Publicado: (2017)

Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study
por: Pasarikovski, Christopher R., et al.
Publicado: (2016)

Successful treatment with nilotinib after bosutinib-induced pulmonary arterial hypertension recurrence following dasatinib in chronic myeloid leukemia in chronic phase
por: Takatsuka, Ibuki, et al.
Publicado: (2022)

Importance of computed tomography in defining segmental disease in chronic thromboembolic pulmonary hypertension
por: McInnis, Micheal C., et al.
Publicado: (2020)

Bosutinib induced pleural effusions: Case report and review of tyrosine kinase inhibitors induced pulmonary toxicity
por: Moguillansky, Natalia I., et al.
Publicado: (2017)

The role of exercise right heart catheterization to guide pulmonary hypertension therapy in older adults
por: Mak, Susanna, et al.
Publicado: (2022)

Bosutinib‐associated interstitial lung disease and pleural effusion: A case report and literature review
por: Liu, Qiuying (Selina), et al.
Publicado: (2021)

Bosutinib-induced lung injury: a report of two cases and literature review
por: Watanabe, Naoki, et al.
Publicado: (2022)

A rare cause of hemoptysis
por: Aversa, Meghan, et al.
Publicado: (2014)

Bosutinib for Chronic Myeloid Leukemia
por: Breccia, Massimo, et al.
Publicado: (2015)

Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain
por: Levinson, Nicholas M., et al.
Publicado: (2012)

High‐grade B‐cell lymphoma developed during the treatment of chronic myeloid leukemia with bosutinib
por: Takakuwa, Teruhito, et al.
Publicado: (2021)

The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario
por: Vaid, Haris M., et al.
Publicado: (2016)

Pregnancy outcomes in patients treated with bosutinib
por: Cortes, Jorge E, et al.
Publicado: (2020)

Bosutinib in the management of chronic myelogenous leukemia
por: Amsberg, Gunhild Keller-von, et al.
Publicado: (2013)

Combination targeted pulmonary hypertension therapy in the resolution of Dasatinib-associated pulmonary arterial hypertension
por: Jose, Arun, et al.
Publicado: (2017)

Epoprostenol‐associated ascites in pulmonary arterial hypertension
por: Schoenberg, Noah C., et al.
Publicado: (2022)

Metabolomic Heterogeneity of Pulmonary Arterial Hypertension
por: Zhao, Yidan, et al.
Publicado: (2014)

Pulmonary hypertension and pulmonary artery dissection
por: Corrêa, Ricardo de Amorim, et al.
Publicado: (2013)

Pulmonary arterial hypertension and pregnancy
por: Terek, Demet, et al.
Publicado: (2013)

Massive dilatation of the pulmonary artery in association with pulmonic stenosis and pulmonary hypertension
por: Morjaria, Sejal, et al.
Publicado: (2012)

Pulmonary arterial hypertension in pregnancy—a systematic review of outcomes in the modern era
por: Low, Ting-Ting, et al.
Publicado: (2021)

Carfilzomib-associated pulmonary arterial hypertension in multiple myeloma
por: Yang, Jenny Z., et al.
Publicado: (2021)

Caveolin‐1 associated with severe (pediatric‐onset) presentation of pulmonary arterial hypertension
por: Farrell, Rachel, et al.
Publicado: (2022)

Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation
por: Uz, B., et al.
Publicado: (2011)

Exhaled Nitric Oxide in Systemic Sclerosis Lung Disease
por: Kozij, Natalie K., et al.
Publicado: (2017)

Left Pulmonary Artery Coarctation Associated with Pneumonia and Pulmonary Hypertension in a Cat
por: Valente, Carlotta, et al.
Publicado: (2021)

Clinical trial design and new therapies for pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2019)

Pulmonary artery ablation to treat pulmonary arterial hypertension: a case report
por: Kiuchi, Márcio Galindo, et al.
Publicado: (2015)

Acute and chronic dissection of pulmonary artery: new challenges in pulmonary arterial hypertension?
por: Florczyk, Michał, et al.
Publicado: (2017)

Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia
por: Mita, Akiko, et al.
Publicado: (2018)

Contrasting haemodynamic effects of exercise and saline infusion in older adults with pulmonary arterial hypertension
por: Valle, Felipe H., et al.
Publicado: (2021)

Pathophysiology, incidence, management, and consequences of cardiac arrhythmia in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Cirulis, Meghan M., et al.
Publicado: (2019)

Control of mammary tumor differentiation by SKI-606 (bosutinib)
por: Hebbard, Lionel, et al.
Publicado: (2010)

Bosutinib in chronic myeloid leukemia: patient selection and perspectives
por: Isfort, Susanne, et al.
Publicado: (2018)

Bosutinib Inhibits EGFR Activation in Head and Neck Cancer
por: Segrelles, Carmen, et al.
Publicado: (2018)

Pulmonary Artery Dissection: A Fatal Complication of Pulmonary Hypertension
por: Zhang, Chuanchen, et al.
Publicado: (2016)

Pulmonary hypertension in an adult with unilateral absence of left pulmonary artery
por: Ghazarian, Armen, et al.
Publicado: (2022)

Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia
por: Hong, Ji Hyung, et al.
Publicado: (2015)

A case of reversible pulmonary arterial hypertension associated with incontinentia pigmenti
por: Atallah, Veronique, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8dbi2oetamep1ertvqvtlgbjnf